Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering

Zhongchao Inc. (NASDAQ: ZCMD), a platform-based internet technology company focused on providing services for patients with cancer and other major diseases, has announced the pricing of a public offering expected to raise approximately $5 million. The offering, which consists of 9,259,260 units, is priced at $0.54 per unit and is set to close on or about June 1, 2026, subject to customary closing conditions. Each unit comprises one Class A ordinary share and one warrant, with the warrants exercisable at an initial price of $0.594 per share.

Zhongchao operates through its variable interest entity, Zhongchao Medical Technology (Shanghai) Limited, and its subsidiaries, which provide a range of healthcare services. These include online healthcare information, professional training for healthcare professionals through their "MDMOOC" platform, and patient management services in oncology and rare diseases. The company's diverse offerings position it well within the growing telehealth sector, which has seen increased demand due to the ongoing digital transformation in healthcare.

The strategic rationale behind this public offering is likely to bolster Zhongchao's capital base to support its expansion plans and enhance its service offerings. The funds raised will enable the company to invest in technology development, expand its service reach, and potentially explore new market opportunities. Given the increasing prevalence of cancer and other major diseases, there is a significant demand for innovative healthcare solutions, making Zhongchao's business model particularly relevant in today's market.

The broader healthcare sector, especially the telehealth segment, has been experiencing robust growth, driven by advancements in technology and a shift towards more accessible healthcare solutions. Investors are increasingly recognizing the potential of companies like Zhongchao that are leveraging technology to improve patient outcomes. As the company moves forward with its public offering, it will be crucial to monitor how the raised capital is utilized and the impact it has on Zhongchao's market position.

In conclusion, Zhongchao Inc.'s public offering represents a strategic move to secure funding for its growth initiatives in the rapidly evolving healthcare landscape. As the company continues to innovate and expand its offerings, it is well-positioned to capitalize on the increasing demand for digital healthcare solutions. The successful closing of this offering may also serve as a positive indicator for investor confidence in the telehealth sector as a whole.